What should I Know Regarding Pregnancy, Nursing and Administering Magmalin Tablet, Chewable to Children or the Elderly?
If you are PREGNANT
- Requires a Risk/Benefit Assessment:
If you are NURSING
- No Known Risk: POOR GI ABSORPTION
- No Known Risk: EXCRETED IN ANIMAL STUDIES;POOR GI ABSORPTION
If you are an adult over 60
- Management or Monitoring Precaution: May cause diarrhea. Caution in renal impairment.
- Management or Monitoring Precaution: May cause constipation. Overuse may affect bone mineralization.
Giving Magmalin Tablet, Chewable to a child under 12
- Management or Monitoring Precaution: Rare risk of osteomalacia with high dose therapy.
- Management or Monitoring Precaution: Limited safety data available. Maintain adequate fluid intake. FDA approval is age 12 and older for use as antacid.
Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.